Palisade Bio has reported positive outcomes from the Phase Ib open-label cohort of an ileocolonic-targeted PDE4 inhibitor, ...

Cosmo Pharmaceuticals on Friday reported the renewal of its multi-year manufacturing and supply agreement with Takeda (TAK), ...

So let’s get into it. Here’s everything you need to know to address uncommon UC symptoms and seize back control of your ...

Juvenile idiopathic arthritis, older age, and concomitant immunomodulation delay the onset of psoriasiform dermatitis in ...

Dawson's Creek actor James van der Beek shares how subtle bowel changes were the first warning sign of his stage 3 colorectal ...

“These results represent a significant milestone for PALI-2108,” said JD Finley, Chief Executive Officer of Palisade Bio. “The early clinical activity, targeted delivery, dose flexibility, the ...

Microbiotica Announces Completion of Recruitment in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients4 August 2025Cambridge, UK – 4 August 2025: ...

Cosmo Pharma & Takeda renew strategic manufacturing pact for global supply of oral treatment for ulcerative colitis: Dublin, Ireland Saturday, August 9, 2025, 15:00 Hrs [IST] Cosm ...

Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) ...

With colorectal cancer on the rise in people under 50, researchers at the University of Illinois Urbana-Champaign are looking ...